Invasion factors uPA/PAI-1 and HER2 status provide independent and complementary information on patient outcome in node-negative breast cancer.

被引：0
|
作者：
Zemzoum, I
Schmitt, M
Ross, JS
Kiechle, M
Harbeck, N
机构：
[1] Tech Univ Munich, D-8000 Munich, Germany
[2] Albany Med Coll, Albany, NY 12208 USA
来源：
BREAST CANCER RESEARCH AND TREATMENT | 2002年 / 76卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
127
引用
收藏
页码：S44 / S44
页数：1
相关论文
共 50 条
  • [21] Health economic impact of risk group selection according to ASCO-recommended biomarkers uPA/PAI-1 in node-negative primary breast cancer
    Volker R. Jacobs
    Ronald E. Kates
    Eva Kantelhardt
    Martina Vetter
    Rachel Wuerstlein
    Thorsten Fischer
    Manfred Schmitt
    Fritz Jaenicke
    Michael Untch
    Christoph Thomssen
    Nadia Harbeck
    Breast Cancer Research and Treatment, 2013, 138 : 839 - 850
  • [22] Health Economic Impact of Risk Group Selection According to ASCO-Recommended Biomarkers uPA/PAI-1 in Node-Negative Primary Breast Cancer
    Jacobs, V. R.
    Kates, R.
    Kantelhardt, E. J.
    Vetter, M.
    Schmitt, M.
    Jaenicke, F.
    Untch, M.
    Thomssen, C.
    Harbeck, N.
    CANCER RESEARCH, 2010, 70
  • [23] HMGA2 with uPAI/PAI-1 as prognostic factors in node negative breast cancer patients
    Wischnewsky, M.
    Boecker, W.
    Meyer, A.
    Milde-Langosch, K.
    Bullerdiek, J.
    BREAST CANCER RESEARCH AND TREATMENT, 2007, 106 : S258 - S258
  • [24] Health economic impact of risk group selection according to ASCO-recommended biomarkers uPA/PAI-1 in node-negative primary breast cancer
    Jacobs, Volker R.
    Kates, Ronald E.
    Kantelhardt, Eva
    Vetter, Martina
    Wuerstlein, Rachel
    Fischer, Thorsten
    Schmitt, Manfred
    Jaenicke, Fritz
    Untch, Michael
    Thomssen, Christoph
    Harbeck, Nadia
    BREAST CANCER RESEARCH AND TREATMENT, 2013, 138 (03) : 839 - 850
  • [25] Effect of HER2 status on risk of recurrence in women with small, node-negative breast tumours
    Tanaka, K.
    Kawaguchi, H.
    Nakamura, Y.
    Taguchi, K.
    Nishiyama, K.
    Ohno, S.
    BRITISH JOURNAL OF SURGERY, 2011, 98 (11) : 1561 - 1565
  • [26] Identification of low-risk node-negative breast cancer patients by tumor biological factors PAI-1 and cathepsin L
    Thomssen, C
    Oppelt, P
    Jänicke, F
    Ulm, K
    Harbeck, N
    Höfler, H
    Kuhn, W
    Graeff, H
    Schmitt, M
    ANTICANCER RESEARCH, 1998, 18 (3C) : 2173 - 2180
  • [27] Clinical significance and future of the prognostic factors uPA and PAI-1 for nodal-negative invasive breast cancer
    Streckert, I
    Bonatz, G.
    Kucharski, K.
    Marek, W.
    Streckert, H. J.
    Phillipou, S.
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2008, 68 (03) : 304 - 304
  • [28] Recurrence risk in T1a-b, node negative, HER2 positive breast cancer.
    Black, D.
    Younger, J.
    Martei, Y.
    Michaelson, J.
    Dominguez, F.
    Bhan, A.
    Burstein, H.
    Winer, E.
    Goss, P.
    Smith, B.
    BREAST CANCER RESEARCH AND TREATMENT, 2006, 100 : S92 - S93
  • [29] Determination of ASCO recommended prognostic factors uPA and PAI-1 in daily clinical routine and the node-negative NNBC 3-Europe trial
    Thomssen, C.
    Vetter, M.
    Geurts-Moespot, A.
    Kantelhardt, E. J.
    Veyret, C.
    Schmidt, M.
    Meisner, C.
    von Minckwitz, G.
    Hanf, V
    Martin, P.
    Augustin, D.
    Abraha-Spaeth, S. R.
    Schmitt, M.
    Sweep, F.
    Paepke, D.
    Harbeck, N.
    CANCER RESEARCH, 2009, 69 (02) : 133S - 133S
  • [30] Determination of ASCO recommended prognostic factors uPA/PAI-1 in clinical routine and the node-negative NNBC 3-Europe therapy trial
    Thomssen, C.
    Vetter, M.
    Kantelhardt, E.
    Geurts-Moespot, A.
    Schmidt, M.
    Veyret, C.
    Meisner, C.
    von Minckwitz, G.
    Hanf, V.
    Martin, P.
    Augustin, D.
    Schmitt, M.
    Sweep, F.
    Paepke, D.
    Harbeck, N.
    BREAST, 2009, 18 : S32 - S32
12345